510(k) K100663
K100663 is an FDA 510(k) premarket notification submitted by Boston Scientific Corporation for the device "CONTOUR EMBOLIZATION PARTICLES, MODELS M0017600121, M0017600221, M0017600321". The FDA issued a decision of Substantially Equivalent on April 16, 2010. The device falls under product code NAJ (Agents, Embolic, For Treatment Of Uterine Fibroids), a Class II device regulated under 21 CFR 870.3300. Boston Scientific Corporation has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 16, 2010
- Date Received
- March 8, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Agents, Embolic, For Treatment Of Uterine Fibroids
- Device Class
- Class II
- Regulation Number
- 870.3300
- Review Panel
- OB
- Submission Type